FIELD: chemistry.
SUBSTANCE: invention refers to novel aminoalkyl-and amodialkylbenzopyran derivatives of the general formula (I): (a), where (a) group is a substitute in 6 or 7 position, where R is mono- or bicyclic (C6-C10)-aryl radical optionally substituted with one or two substitutes selected out of linear or ramified (C1-C5)-alkyls, linear or ramified (C1-C5)-alkoxy, hydroxy, halogen and trifluoromethyl; m is zero or integer 1-3; n, p, R1 and R2 are as indicated in the description, and both R3 and R4 are hydrogen or both are oxygen: and to pharmaceutically acceptable salts thereof.
EFFECT: selective reversible MAO-B inhibitors in vitro and in vivo, applicable as medicines for prevention and treatment of degenerative central nervous system disorders.
13 cl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
2-PHENYLETHYLAMINO DERIVATIVES AS CALCIUM AND/OR SODIUM CHANNEL MODULATORS | 2006 |
|
RU2397160C9 |
PHENYLIMIDAZOLE COMPOUNDS | 2010 |
|
RU2497811C2 |
PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND METHODS FOR MAKING THEREOF | 2005 |
|
RU2375359C2 |
C-PHENYL GLYCITOL COMPOUND FOR TREATING DIABETES | 2007 |
|
RU2437876C2 |
VIRAL REPLICATION INHIBITORS, METHOD FOR PRODUCTION THEREOF AND THERAPEUTIC APPLICATIONS THEREOF | 2014 |
|
RU2678575C2 |
THIOPHENE DERIVATIVE AND ITS USE | 2019 |
|
RU2781643C2 |
ALPHA-AMINOAMIDE DERIVATIVES USED FOR TREATING LOWER URINARY TRACT DISORDERS | 2005 |
|
RU2395504C2 |
ANTIVIRAL COMPOUND | 2006 |
|
RU2441010C2 |
SUBSTITUTED AZOL DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES, AND METHODS OF TREATING PARKINSON'S DISEASE WITH USING THESE DERIVATIVES | 2010 |
|
RU2578596C2 |
N-(AZAARYL)CYCLOLACTAM-1-CARBOXAMIDE DERIVATIVE, ITS PREPARATION METHOD AND ITS APPLICATION | 2018 |
|
RU2765785C2 |
Authors
Dates
2010-06-20—Published
2006-02-22—Filed